Efficacy and Safety of Azilsartan Compared to Olmesartan Medoxomil in Chinese Participants With Grade I or II Essential Hypertension
Clinical trial NCT02407210 · UNKNOWN
Trial details
- NCT number
- NCT02407210
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2015-10-01
- Enrollment
- 304
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.